Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study - Concepedia

Concepedia

Publication | Closed Access

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

400

Citations

23

References

2012

Year

John Farley, William E. Brady, Vinod Vathipadiekal, Heather A. Lankes, Robert L. Coleman, Mark A. Morgan, Robert S. Mannel, S. Diane Yamada, David G. Mutch, William H. Rodgers,

The Lancet Oncology

Tumoral PathologyGenitourinary CancerMedicinePathologyGynecologyOncologyGynecology OncologyCancer ResearchEndocrine-related CancerOvarian Cancer

References

	Year	Citations

Page 1

Page 1